BioRestorative Therapies Inc., a fully integrated regenerative medicine company, has released an investor presentation detailing its ongoing projects and leadership team. The presentation highlights the company's focus on developing stem cell-based therapies, including brown adipose-derived stem cells and bone marrow-derived mesenchymal stem cells. These initiatives are in various stages, from preclinical to mid-stage clinical development. The presentation also outlines the company's work on Secretome, a biologics-based technology for cosmetic applications. Lance Alstodt serves as the Chairman and CEO, while Francisco Silva is the Vice President of R&D, bringing extensive experience in stem cell research and development. You can access the full presentation through the link below.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。